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Abstract
Purpose
To investigate macular ganglion cell–inner plexiform layer (mGCIPL) thickness in glaucoma-
tous eyes with visible localized retinal nerve fiber layer (RNFL) defects on stereophotographs.
Methods
112 healthy and 149 glaucomatous eyes from the Diagnostic Innovations in Glaucoma
Study (DIGS) and the African Descent and Glaucoma Evaluation Study (ADAGES) subjects
had standard automated perimetry (SAP), optical coherence tomography (OCT) imaging of
the macula and optic nerve head, and stereoscopic optic disc photography. Masked observ-
ers identified localized RNFL defects by grading of stereophotographs.
Result
47 eyes had visible localized RNFL defects on stereophotographs. Eyes with visible local-
ized RNFL defects had significantly thinner mGCIPL thickness compared to healthy eyes
(68.3 ± 11.4 μm versus 79.2 ± 6.6 μm respectively, P<0.001) and similar mGCIPL thickness
to glaucomatous eyes without localized RNFL defects (68.6 ± 11.2 μm, P = 1.000). The
average mGCIPL thickness in eyes with RNFL defects was 14% less than similarly aged
healthy controls. For 29 eyes with a visible RNFL defect in just one hemiretina (superior or
inferior) mGCIPL was thinnest in the same hemiretina in 26 eyes (90%). Eyes with inferior-
temporal RNFL defects also had significantly thinner inferior-temporal mGCIPL (P<0.001)
and inferior mGCIPL (P = 0.030) compared to glaucomatous eyes without a visible RNFL
defect.
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Conclusion
The current study indicates that presence of a localized RNFL defect is likely to indicate sig-
nificant macular damage, particularly in the region of the macular that topographically corre-
sponds to the location of the RNFL defect.
Introduction
Glaucoma is characterized by loss of retinal ganglion cells (RGCs) and their axons that mani-
fests clinically as structural changes to the optic nerve head (ONH) and circumpapillary retinal
nerve fiber layer (cpRNFL). [1,2] These changes are accompanied by a reduction in visual field
sensitivity, which without adequate treatment, may progress to visual impairment and blind-
ness. [3,4]
Glaucomatous damage to the ONH and cpRNFL can be observed directly using biomicro-
scopy or recorded using optic disc stereophotographs. Damage may also be quantified using
imaging devices such as confocal scanning laser ophthalmoscopy, scanning laser polarimetry,
[5,6] or optical coherence tomography (OCT). [7–9] Although imaging in glaucoma has tradi-
tionally focused on the ONH and cpRNFL, recent advances in OCT have provided the means
to image the inner retina and obtain quantitative measurements of macular structures includ-
ing the retinal ganglion cell layer–the location of retinal ganglion cell bodies. [10] The macular
ganglion cell layer is of particular interest due to its importance for central vision and the high
density of RGCs in this region. [11–13] In fact, previous studies have demonstrated the value
of macular thickness measurements for glaucoma diagnosis using various parameters, includ-
ing macular ganglion cell-inner plexiform layer (mGCIPL) thickness, which is the combination
of the ganglion cell and inner plexiform layer. [14–19]
Glaucomatous damage may be diffuse or localized. Diffuse RGC loss is manifest by general-
ized loss of RNFL striations, a darkened appearance to the inner retina due to reduced reflectiv-
ity of RGC axon bundles constituting the RNFL, and increased visibility of the retinal blood
vessels, which normally are embedded in the RNFL. [2,20–22] Localized damage can lead to
localized RNFL defects, which are visible on stereophotographs as wedge shaped defects that
become narrower towards the disc margin due to convergence of RNFL bundles.
RNFL defects are often among the earliest observable clinical signs of glaucoma. [22,23] As
localized RNFL defects may be a consequence or cause of the loss of RGC axons, it is important
to understand the topographic relationship between RNFL and mGCPIL thickness in eyes with
localized RNFL damage. Hood et al has recently proposed a map of the topographic relation-
ship between RNFL and GCL. In this model, the superior RNFL maps to the temporal and tem-
poral superior GCL, while the inferior RNFL generally maps to the inferior GCL. [10,24]
The purpose this study was to examine the spatial relationship between RNFL defects and
mGCIPL thickness in glaucoma patients with visible localized RNFL defects visible on optic
disc stereophotographs and to compare to mGCIPL thickness measurements in healthy eyes
and glaucomatous eye without visible localized RNFL defects.
Methods
Study Design
This was a cross-sectional study of 261 eyes of 261 patients recruited from 2 prospective longi-
tudinal studies: the African Descent and Glaucoma Evaluation Study and the Diagnostic
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Innovations in Glaucoma Study. Methodological details have been described previously. [25]
Patients were recruited from 3 sites; Hamilton Glaucoma Center at the Shiley Eye Institute and
Department of Ophthalmology, University of California, San Diego (UCSD) (data coordinat-
ing center); the New York Eye and Ear Infirmary; and the Department of Ophthalmology,
University of Alabama, Birmingham. Written informed consent was obtained from all the par-
ticipants, and the institutional review boards and human subjects committees of all 3 sites pro-
spectively approved the methods. All methods adhered to the tenets of the Declaration of
Helsinki for research involving human subjects, and the study was conducted in accordance
with Health Insurance Portability and Accountability Act regulations.
At each annual visit, subjects underwent a comprehensive ophthalmologic examination
including review of medical history, visual acuity, slit-lamp biomicroscopy, intraocular pres-
sure measurement, dilated fundoscopic examination and simultaneous stereoscopic optic disc
photography (Kowa NonmydWX3D, software version VK27E, Kowa Company Ltd, Tokyo
Japan) with a field angle of 34 degrees. At each biannual visit, Cirrus HDOCT (software version
6.5; Carl Zeiss Meditec, Inc. Dublin, CA), images and standard automated perimetry (SAP)
using the Swedish interactive threshold algorithm (SITA standard 24–2; Carl Zeiss Meditec,
Inc, Dublin, California, USA) tests were performed. Only subjects with open angles on gonio-
scopy were included. Subjects were excluded if at their qualifying visit, they had a best-cor-
rected visual acuity of less than 20/40; spherical refraction outside ± 5.0 diopters, cylinder
correction outside 3.0 diopters, or both; or any other ocular or systemic disease that could affect
the optic nerve or the visual field. Axial length was measured using the IOL Master (Carl Zeiss
Meditec, Dublin, CA) at study entry.
Eyes were classified as glaucomatous if they had repeatable ( 3 consecutive) abnormal
SAP test results on the 24–2 program of the visual field analyzer (Humphrey Field Analyzer
[HFA II-i]; Carl Zeiss Meditec, Inc., Dublin, CA) or progressive glaucomatous optic disc
changes on masked examination of optic disc stereophotographs, with or without an abnormal
SAP result. All visual fields were evaluated for quality by the UCSD Visual Field Assessment
Center. [26] Visual fields with more than 33% fixation losses or more than 15% false-positive
errors, or evidence of learning effects or other artifacts were excluded. An abnormal SAP result
was defined as having a pattern standard deviation outside the 95% confidence limits or a glau-
coma hemifield test outside the reference range. Healthy subjects were recruited from the gen-
eral population through advertisements, primary care ophthalmic clinics and from the staff
and employees of the UCSD. Healthy eyes had intraocular pressure (IOP) 21 mmHg, with
no history of elevated IOP and a normal SAP result. The healthy group was matched for age
with the group with visible localized RNFL defects. A sample of subjects with glaucoma without
visible localized RNFL defects was selected for inclusion in the study and also matched to the
age of the group with visible localized RNFL defects.
Stereophotograph Grading. Digital stereoscopic images were reviewed with a stereo-
scopic viewer (Screen-VU stereoscope; PS Manufacturing, Portland, Oregon, USA) by 2 or
more experienced graders. Details of the methodology used to grade optic disc stereophoto-
graphs at the UCSD Optic Disc Reading Center have been provided elsewhere. [25,27,28] In
brief, each grader was masked to the subject’s identity and to the other test results. Eyes with
localized RNFL defects were identified by at least 2 graders. Localized RNFL defects were
defined as defects wider than twice the width of an arteriole, extending from close to the disc
margin into the peripapillary area, widening en route. (i.e., wedge shaped). [29] Slit defects nar-
rower than the diameter of adjacent vessels were not considered as localized RNFL defects con-
sistent with glaucoma because they are found frequently in normal eyes. [2,30]
The position of the RNFL defects at the optic disc was also assessed by graders and a clock
hour numbering was adjusted to numbering of the right eye in order to allow comparison
Macular Structural Changes with Localized Retinal Nerve Fiber Layer Defects
PLOS ONE | DOI:10.1371/journal.pone.0160549 August 18, 2016 3 / 13
between right and left eyes, Therefore the superior-temporal region would be assigned the
same clock hours in a right or left eye.
Optical Coherence Tomography. Cirrus HDOCT was used to acquire measurements of
cpRNFL and mGCIPL thickness. Cirrus HDOCT uses a superluminescent diode scan with a
center wavelength of 840 nm and an acquisition rate of 27,000 A-scans per second at an axial
resolution of 5μm. The optic disc cube 200 x 200 protocol was used to acquire RNFL thickness
measurements. This protocol is based on a 3-dimensional (3D) scan of a 6 x 6 mm area cen-
tered on the optic disc in which information from a 1024 (depth) x 200 x 200 point parallelepi-
ped is collected. The RNFL thickness measurements were calculated from a 3.46-mm diameter
circular scan (10,870 μm in length) automatically placed around the optic disc by the OCT soft-
ware. Measurements were analyzed using 12 clock hour sectors.
The macular cube 200 x 200 protocol was used to acquire macular thickness data. This pro-
tocol is based on a 3D scan centered on the macula in which information from a 1024 (depth)
x 200 x 200 point parallelepiped is collected. The ganglion cell analysis algorithm automatically
segmented the GCIPL between the outer boundary of RNFL and the outer boundary of IPL
based on three-dimensional data generated from the macular cube scan protocol. [31,32] The
Cirrus HDOCT images were reviewed for quality by the Imaging Data Evaluation and Analysis
(IDEA) Center. Images were included if the signal strength was 7, if movement artifacts and
segmentation errors were absent, and there was good centering on the optic disc or fovea for
the optic disc and macular cube protocols, respectively. Measurements were analyzed in 6 sec-
tors as provided by the instrument software, superior, superior nasal, superior temporal, infe-
rior, inferior nasal and inferior temporal. Foveal placement was manually adjusted as needed.
Statistical Analysis. One-way analysis of variance (ANOVA) with post-hoc analysis was
done using Scheffe test to determine differences of baseline characteristics and mGCIPL mea-
surements among the healthy group, the group with localized visible RNFL defects and the
group without localized visible RNFL defects.
We also calculated the percentage of loss from mGCIPL in the glaucoma group in compari-
son to the healthy group. Measurements from the healthy control group were used to deter-
mine the expected mGCIPL for each sector using a linear regression model. Age and axial
length were included in this model since these variables have been shown to influence mGCIPL
and cpRNFL thickness measurements. [33] In healthy eyes group, age (P = 0.004) and axial
length (P< 0.001) were significantly associated with mGCIPL (R2 = 0.23) in the multivariable
model. Age (P = 0.016) and axial length (P = 0.046) were also significantly associated with
cpRNFL thickness. The models had the following general form:
Expected mGCIPL thickness ¼ constant þ b1age þ b2 axial length
Estimated mGCIPL percentage lost
¼ ½ðexpected mGCIPL  observed mGCIPLÞ =expected mGCIPL100
Expected cpRNFL thickness ¼ constantþ b3age þ b4 axial length
Estimated cpRNFL thickness percentage lost
¼ ½ðexpected cpRNFL  observed cpRNFLÞ =expected cpRNFL100
All statistical analyses were performed with commercially available software (STATA, ver-
sion 13; Stata Corp LP, College Station, TX). The alpha level (type I error) was set at 0.05.
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Results
The study included 47 glaucomatous eyes (47 subjects) with localized RNFL defects visible on
stereophotographs (RNFL defect group), 102 glaucomatous eyes (102 subjects) without visible
localized RNFL defects (without localized RNFL defect group) and 112 eyes from 112 healthy
subjects. There was no significant difference in age between groups (Table 1).
Overall glaucomatous eyes with and without localized RNFL defects visible on stereophoto-
graphs had similar disease severity, measured by SAP MD, with average MD of -5.8 ± 5.7 dB
and -6.4 ± 6.6 dB respectively (Table 1). There was also no difference in average cpRNFL thick-
ness or mGCIPL thickness between glaucomatous eyes with and without visible RNFL defects
(Table 1). Average cpRNFL thicknesses were 71.7 ± 9.6, 72.9 ± 15.0 and 91.6 ± 10.0 μm in glau-
comatous eyes with and without visible localized RNFL defects and healthy eyes respectively,
with corresponding mGCIPL thicknesses of 68.3 ± 11.4, 68.6 ± 11.2 and 79.2 ± 6.6 μm.
Of the 47 eyes with a visible localized RNFL defect, 29 had only one defect visible and 18
had 2 localized RNFL defects. 44 eyes had an inferior-temporal RNFL defect (clock hours 6, 7
or 8) and 21 had a superior-temporal RNFL defect (clock hours 10, 11 or 12). 26 glaucomatous
eyes had an isolated inferior -temporal RNFL defect and 3 glaucomatous eyes had an isolated
superior -temporal RNFL defect. The most common sectors with localized RNFL defects were
7 o’clock, 6 o’clock and 11 o’clock (Table 2 and Fig 1). The number of eyes with mGCIPL thick-
ness outside normal limits (thinner than 1% of the Cirrus HDOCT reference database of
healthy eyes, which corresponds to red sectors on the Cirrus HDOCT deviation map) in each
sector is shown in Table 2.
40 of 47 eyes (85.1%) with a localized RNFL defect had at least one mGCIPL sector outside
normal limits, compared to 13 of 112 healthy eyes (11.6%, P<0.001) and 69 of 102 glaucoma-
tous eyes without a localized RNFL defect visible on stereophotographs (67.6%, P<0.001).
There was spatial agreement between the location of visible localized RNFL defects and the
location of mGCIPL sectors outside normal limits. For example, 16 of 18 eyes (89%) with an
isolated RNFL defect involving 7 o’clock (inferior-temporal position) on stereophotographs
had an inferior-temporal mGCIPL thickness outside normal limits, compared to 13 eyes (72%)
with an abnormal inferior mGCIPL thickness, with other sectors less commonly affected
(Table 2). Similar results were found for eyes with both inferior-temporal and superior-tempo-
ral RNFL defects (Table 2). 12 of 15 eyes (80%) with localized RNFL defects visible at 11 o’clock
(superior-temporal position) had a superior-temporal mGCIPL thickness outside normal lim-
its–with superior and superior-nasal mGCIPL thickness also affected. The average mGCIPL
thickness was thinnest in the hemiretina corresponding to the visible RNFL defect in 26 of 29
eyes (90%) with one localized RNFL defect.
Table 3 shows mGCIPL thicknesses in each sector for eyes with inferior-temporal RNFL
defects compared to eyes without visible localized RNFL defects. Although overall glaucomatous
eyes included in this study had similar disease severity, eyes with localized RNFL loss visible on
stereophotographs had evidence of greater localized mGCIPL thickness loss at the expected
location based on the Hood et al map. [10] For example, eyes with inferior-temporal RNFL
defects had significantly thinner inferior and inferior-temporal mGCIPL thickness than glauco-
matous eyes without localized RNFL defects (61.7 ± 12.4 and 66.9 ± 12.8, P = 0.030 and
59.3 ± 11.0 and 67.8 ± 12.1μm, P<0.001 respectively, Table 3). Eyes with inferior or inferior-
temporal RNFL defects had significantly thinner mGCIPL compared to healthy eyes in all sec-
tors (Table 3). In our study, there were 21 eyes with superior-temporal RNFL defects but only 3
eyes with isolated superior-temporal RNFL defects. We also found that in the 21 eyes with supe-
rior-temporal RNFL defects (10,11 and 12 o’clock) tended to have thinner superior-temporal
mGCIPL compared to glaucomatous eyes without localized RNFL defects, but the difference did
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not reach statistical significance (62.8 ± 11.1μm versus 67.6 ± 11.2μm, P = 0.104). The result is
likely in part due to insufficient sample size to examine this.
Fig 2 shows the regional distribution of mGCIPL thickness, and estimated percentage loss of
mGCIPL and cpRNFL thickness in glaucomatous eyes with inferior-temporal defects compared
to glaucomatous eyes without a visible RNFL defect and healthy eyes. Examples of eyes with
localized RNFL defects visible on stereophotographs included in the study are shown in Fig 3.
Discussion
Recently, there has been renewed emphasis on the importance of evaluating the macula in glau-
coma diagnosis and management. [16] Glaucomatous damage to the macula is common, can
occur early in the disease, and can be missed and/or underestimated with standard visual field
tests. [10] The present study shows that patients with localized RNFL defects visible on stereo-
photographs may have substantial macular damage, with potentially important implications
for visual function.
Patients with localized RNFL defects visible on stereophotographs had an average mGCIPL
thickness of 68.3 ± 11.4 μm, which was 14% less than healthy subjects of a similar age. There-
fore, although RNFL defects are considered one of the earliest changes of glaucoma and often
precede noticeable change of the ONH and visual field, the current study suggests they may be
associated with detectable mGCIPL losses. [22,23,34] In eyes with localized RNFL defects,
Table 1. Summary of demographic and clinical characteristics of healthy eyes compared to glaucomatous eyes with and without localized RNFL
defects visible on optic disc stereo photography.
Characteristics Healthy 112 eyes(112
subjects)
Glaucoma with localized RNFL
defect 47 eyes (47subjects)
Glaucoma without localized RNFL
defect 102 eyes (102 subjects)
Different among three
groups (P-value*)
Age (years) 60.8 ± 10.1 63.5 ± 10.2 63.3 ± 10.3 0.132
Female gender n
(%)
68 (61%) 33 (70%) 53 (52%) 0.097**
Ancestry
European 38 (34%) 18 (38%) 40 (39%) 0.117**
African 72 (64%) 24 (51%) 58 (57%)
Other 2 (2%) 5 (11%) 4 (4%)
Axial length (mm) 23.8 ± 0.9 23.7 ± 0.8 24.0 ± 1.0 0.154
CCT (μm) 540.5 ± 38.5 528.5 ± 43.5 535.3 ± 38.0 0.203
SAPMD (dB) 0.3 ± 1.1 -5.8 ± 5.7 -6.4 ± 6.6 < 0.001†‡
PSD (dB) 1.6 ± 0.4 7.3 ± 4.4 6.5 ± 4.3 < 0.001†‡
SAP VFI (%) 99.3 ± 0.8 81.9 ± 17.9 82.5 ± 19.4 < 0.001†‡
cpRNFL thickness
(μm)
91.6 ± 10.0 71.7 ± 9.6 72.9 ± 15.0 < 0.001†‡
mGCIPL thickness
(μm)
79.2 ± 6.6 68.3 ± 11.4 68.6 ± 11.2 < 0.001†‡
Values are mean ± standard deviation unless specified otherwise.
* p-values are based on one-way analysis of variance with post-hoc Scheffe for two groups
**Fisher’s exact test.
Abbreviations: CCT = Central corneal thickness; SAP = standard automated perimetry; MD = mean deviation; PSD = pattern standard deviation; VFI = visual
field index; cpRNFL = circumpapillary retinal nerve fiber layer; mGCIPL = macular ganglion cell layer plus inner plexiform layer.
† P indicate statistically significant differences between healthy eyes and glaucomatous eyes without localized RNFL defect using one-way analysis of
variance with post-hoc Scheffe (p < 0.001).
‡ P indicate statistically significant differences between healthy eyes and glaucomatous eyes with localized RNFL defect using one-way analysis of variance
with post-hoc Scheffe (p < 0.001).
doi:10.1371/journal.pone.0160549.t001
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mGCIPL thickness ranged from 28 to 88 μm, reflecting an average estimated loss of 11% to
63%. Average mGCIPL thickness was also reduced in the expected sectors that correspond to
visible RNFL defects. For example, in healthy eyes the inferior-temporal mGCIPL average thick-
ness was 79.8 μm, while in eyes with inferior-temporal RNFL defects, the average inferior-tem-
poral mGCIPL thickness was 59.3 μm, which was 26% less than that expected in a healthy eye.
Our results are generally consistent with Hood et al’s map of the relationship between the
location of RNFL and macular damage. They also are consistent with the idea that there is a
macular vulnerability zone that is particularly susceptible to damage. [24] In eyes with inferior-
temporal RNFL defects, the GCIPL tended to be thinner in the inferior and inferior-temporal
region. Further, in eyes with RNFL superior damage, the GCIPL was thinner in the superior
and superior-temporal macular region. Specifically, most eyes with inferior-temporal RNFL
defects located at 6 o-clock and 7 o-clock detected on stereophotographs had inferior or
Table 2. Frequency of macular ganglion cell inner plexiform layer (mGCIPL) sectors outside normal limits for glaucomatous eyes with localized
retinal nerve fiber layer (RNFL) defects involving the inferior-temporal region (6, 7 or 8 o’clock) alone (A) and for glaucomatous eyes with localized
RNFL defects involving the inferior-temporal and superior-temporal regions (B).
Location of RNFL defect on
optic disc photography
(Clock hour)
Number of Eyes (eyes counted
multiple times if more than
one clock hour involved)
Number of eyes with mGCIPL sectors outside
normal limits (%)*
ST S SN IN I IT
Eyes with inferior-temporal
RNFL defect only (26 eyes)
6 o’clock 13 5
(38%)
2
(15%)
2
(15%)
3
(23%)
8
(62%)
10
(77%)
7 o’clock 18 5
(28%)
3
(17%)
4
(22%)
3
(17%)
13
(72%)
16
(89%)
8 o’clock 2 1
(50%)
1
(50%)
1
(50%)
2
(100%)
2
(100%)
2
(100%)
Eyes with both superior
-temporal and inferior-
temporal RNFL defects (18
eyes)
6 o’clock 9 6
(67%)
4
(44%)
3
(33%)
3
(33%)
5
(56%)
6
(67%)
7 o’clock 13 11
(85%)
7
(54%)
4
(31%)
5
(38%)
10
(77%)
11
(85%)
8 o’clock 3 3
(100%)
3
(100%)
2
(67%)
1
(33%)
1
(33%)
1
(33%)
*Outside normal limits (<1%) compared to the Cirrus reference database of healthy eyes.
Abbreviations: mGCIPL = macular ganglion cell layer plus inner plexiform layer; ST = Superior–temporal section region to mGCIPL; S = Superior section
region to mGCIPL; SN = Superior- Nasal section region to mGCIPL; IN = Inferior-Nasal section region to mGCIPL; I = Inferior section region to mGCIPL;
IT = Inferior–temporal section region to mGCIPL.
doi:10.1371/journal.pone.0160549.t002
Fig 1. Bar graph of the distribution of eyes with visible localized retinal nerve fiber layer (RNFL)
defects on optic disc stereophotography by clock-hour.
doi:10.1371/journal.pone.0160549.g001
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inferior- temporal thickness outside normal limits. Similarly, most eyes with superior RNFL
damage at 10 o-clock and 11 o-clock positions have damage in the superior-temporal macular
region. Moreover, few eyes with localized superior RNFL defects at 12 o-clock had GCIPL
damage outside normal limits in the area measured, as the nerve fibers tend to project superi-
orly outside of the standard GCIPL measurement area.
To the best of our knowledge, there are no histological studies specifically examining macula
changes in eyes with localized RNFL defects based on stereophotographs, however a previous
histological study has shown that localized RNFL defects were only visible on photographs
once there was a 28 to 45% reduction in RNFL. [2] We found average cpRNFL thickness in
eyes with localized RNFL defects was 71.7 ± 9.6μm, or 22% less than healthy subjects. Com-
pared to RNFL thickness in healthy eyes, RNFL loss in sectors corresponding to the RNFL
defect visible on optic disc stereophotographs averaged almost 37%. Tatham and colleagues
recently estimated that patients with localized RNFL defects are associated with a loss of 32%
of retinal ganglion cells in affected sectors. [35] Recently, Kim and colleagues have produced a
mGCIPL deviation frequency map showing the topographic relationship between mGCIPL
defects and cpRNFL defects on OCT. [36] The same group have also demonstrated mGCIPL
thickness to have similar ability to detect glaucomatous eyes with localized RNFL defects com-
pared to cpRNFL measurements. [37] These studies have enhanced our understanding of the
relationship between cpRNFL and mGCIPL loss in glaucoma but longitudinal studies are
needed to examine the temporal relationship between changes in these structures. Future work
Table 3. Summary of macular ganglion cell inner plexiform layer (mGCIPL) thickness in healthy eyes compared to glaucomatous eyes without vis-
ible localized RNFL defects and with visible localized RNFL defects involving inferior and inferior-temporal region (6, 7 or 8 o’clock).
Characteristics 112 eyes
(112
subjects)
Glaucoma with localized
RNFL defect at 6, 7, or 8
o’clock 44 eyes (44
subjects)
Glaucoma without
localized RNFL defect
102 eyes(102
subjects)
Glaucoma with localized
RNFL defect at 6, 7, or 8
o’clock Vs. healthy (P-
value)*
Glaucoma with localized RNFL
defect at 6, 7, or 8 o’clock Vs.
Glaucoma without localized
RNFL defect (P-value)*
mGCIPL thickness-
total (μm)
79.2 ± 6.6 67.9 ± 11.4 68.6 ± 11.2 < 0.001 0.929
mGCIPL thickness–
lower half (μm)
79.0 ± 6.6 64.4 ± 11.0 68.0 ± 12.2 < 0.001 0.148
Inferior- Temporal
mGCIPL thickness
(μm)
79.8 ± 6.5 59.3 ± 11.0 67.8 ± 12.1 < 0.001 < 0.001
Inferior mGCIPL
thickness (μm)
78.2 ± 7.2 61.7 ± 12.4 66.9 ± 12.8 < 0.001 0.030
Inferior- Nasal
mGCIPL thickness
(μm)
79.0 ± 7.3 72.3 ± 12.5 69.2 ± 13.0 0.002 0.306
Superior- Temporal
mGCIPL thickness
(μm)
78.2 ± 6.9 67.3 ± 14.0 67.6 ± 11.2 < 0.001 0.979
Superior mGCIPL
thickness (μm)
79.5 ± 7.2 71.5 ± 15.5 68.9 ± 12.5 < 0.001 0.418
Superior- Nasal
mGCIPL thickness
(μm)
80.3 ± 7.7 75.4 ± 15.6 71.1 ± 12.0 0.051 0.106
Values are mean ± standard deviation and
*One-way analysis of variance with post-hoc Scheffe for two groups.
Abbreviations: MD = mean deviation; PSD = pattern standard deviation; SAP = standard automated perimetry; MD = mean deviation; mGCIPL = macular
ganglion cell layer plus inner plexiform layer.
doi:10.1371/journal.pone.0160549.t003
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Fig 2. Pie charts showing the regional distribution of macular ganglion cell layer plus inner plexiform layer
(mGCIPL) thickness (A), estimated percentage loss of mGCIPL thickness (B) and estimated percentage loss
of circumpapillary retinal nerve fiber layer (cpRNFL) thickness (C) in 112 healthy eyes, 102 glaucomatous
eyes without visible retinal nerve fiber layer (RNFL) defects (Glaucoma 1) and 44 glaucomatous eyes with a
visible inferior -temporal RNFL defect (Glaucoma 2).
doi:10.1371/journal.pone.0160549.g002
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Fig 3. Example of a glaucomatous eye with a localized retinal nerve fiber layer (RNFL) defect at 6 and 7 o’clock (arrows) visible on
photography and optical coherence tomography RNFL deviation and thickness maps (A). There is corresponding localized
inferior-temporal macular ganglion cell-inner plexiform layer thinning (B) and a paracentral defect visible on standard automated
perimetry (SAP). The average percentage estimatedmGCIPL loss for this patient was 6.5%, with a 17.9% estimated loss in the
inferior-temporal mGCIPL sector.
doi:10.1371/journal.pone.0160549.g003
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in this area may lead to improved understanding of the mechanisms of glaucomatous damage
and identify methods to better detect glaucoma.
Localized RNFL defects are areas of abnormality within areas of relatively preserved RNFL
[38], and therefore, the visibility of a localized RNFL defect depends on the thickness and
arrangement of the RNFL in neighboring regions. However, eyes with localized RNFL loss
often also have diffuse loss, and localized RNFL defects tend to progress by deepening and wid-
ening to become diffuse defects. [30,39] The diffuse loss on the cpRNFL thickness could also
reflect a diffuse macular damage. For example, from Tables 2 and 3 it is apparent that although
eyes with inferior or inferior-temporal RNFL defects had maximal mGCIPL loss in the infe-
rior-temporal sectors compared to healthy subjects, the mGCIPL was also thinner in all sectors.
The mGCIPL was thinner, however, in sectors that topographically map to the location of the
RNFL defects compared to sectors which do not map directly to the RNFL defect location, and
compared to sectors of healthy eyes (Table 3).
The study has some limitations. Identification of localized RNFL defects was based on
stereophotographs rather than HDOCT, however this was integral to the study as we wished to
ascertain mGCIPL losses associated with clinically visible RNFL defects and hypothesized that
visible RNFL defects would be associated with large mGCIPL losses. Nevertheless, it is possible
that some glaucomatous eyes may have had localized RNFL defects that were not detected.
Efforts were taken to minimize this possibility by having 2 masked graders assess the stereo-
photographs. It is also possible that differences in alignment between stereophotographs and
HDOCT may have introduced error in our analysis of spatial agreement between RNFL defects
and mGCIPL loss. However, this would not have affected the average measurements, moreover
all images were reviewed for quality and we examined the spatial relationship between RNFL
defects and mGCIPL using large sectors that would be less subject to differences in alignment.
Future studies should also investigate the longitudinal relationship between mGCIPL thickness
in eyes with localized RNFL defects.
Despite limitations, identification of RNFL defects on stereophotographs or slit lamp biomi-
croscopy remains an important component of the clinical examination in those with glaucoma
or suspected glaucoma. The current study indicates that the presence of a localized RNFL
defect is also likely to indicate significant macular damage, particularly in the region of the
macular that topographically corresponds to the location of the RNFL defect. Although visible
localized RNFL defects are considered an early sign of glaucoma, they are in fact associated
with significant glaucomatous macular neural losses.
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